| |
Total Hip and Knee replacements *
|
S
|
P
|
O
|
|
2b
|
% of patients that was administered thrombosis prophylaxis for 6 weeks to 3 months post-surgery, in case of total hip or knee surgery
| |
X
| |
|
4b
|
% of patients that did not (2008 & 2009)/ did (2010) receive a homologue blood transfusion, in case of total hip or knee surgery
| |
X
| |
|
5b
|
% of patients that was administered antibiotics perioperatively
| |
X
| |
|
5c
|
% of patients that was administered antibiotics 15 to 60 min. prior to surgery or to blood emptiness
| |
X
| |
|
5d
|
% of patients with a deep wound infection after a total hip or knee replacement
| | |
X
|
| |
Breast Cancer **
|
S
|
P
|
O
|
|
1
|
% of patients who were seen by a breast cancer nurse specialist preoperatively
| |
X
| |
|
2
|
% of patients that was reviewed preoperatively in a multi-disciplinary team meeting
| |
X
| |
|
3
|
% of patients with a non-radical primary tumor resection
| | |
X
|
|
4
|
% of surgeons in the surgery department that perform surgical treatments of breast tumors
|
X
| | |
|
5
|
% of patients that are operated within 4 weeks after the final lab results are known
| |
X
| |
|
6a
|
% of patients with local recurrences within 5 years after breast-conserving surgery
| | |
X
|
|
6b
|
% of patients that have local recurrences within 5 years after ablative breast surgery
| | |
X
|
|
7
|
% of patients with a breast tumor that was postoperatively reviewed in a documented multi-disciplinary team meeting
|
X
| | |
